Coronaviruses are a large family of viruses which may cause illness in animals or humans. COVID-19 is the name given to the infectious disease caused by the most recently discovered novel coronavirus, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. Not everyone who is infected with SARS-CoV-2 will end up getting sick with the disease, COVID-19, and people can have anything from no symptoms at all to being mildly sick or severely ill. There is actually no reason to suggest that people infected with HIV who are receiving good medication are at a greater risk of developing coronavirus, the COVID-19-causing virus. There's still no reason to think that if you handle your HIV well you'd be more likely to have serious COVID-19 symptoms. People living with HIV who have a compromised immune system should be extra cautious to prevent coronavirus infection. These include people with a low CD4 count (<200 copies/cell), a high viral load, or a recent opportunistic infection (for example, tuberculosis (TB)). Both people living with HIV should take the appropriate steps to protect themselves against coronavirus and ensure they stick to their antiretroviral medication properly. Your doctor or health care company will let you know if they want in this pandemic to change the way they provide the services. Immune deficiency, suggested by a small CD4 T-cell count (< 200 / μl), or not undergoing antiretroviral therapy, must also be believed to be correlated with an elevated risk for a more serious presentation of disease. Nonetheless, evidence in these cases is scarce since most HIV-coinfected COVID-19 cases have been treated successfully with largely suppressed levels of HIV-RNA until now under antiretroviral therapy. Remember to initiate opportunistic infection (OI) prophylaxis in patients with low CD4-counts (< 200 / ml), or who experience a CD4-decline during a COVID-19 infection. This review tells about the future scope of the new invention towards the field of HIV /AIDS and their medicinal treatment. People who are interested can send their article towards our journal for publication through this link https://www.scholarscentral.org/submissions/hiv-aids-research.html.